The chairperson of a political action committee with multiple links to a conservative dark money group that ran multiple controversial [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
The 119th Congress officially convened last week, kicking-off a two-year term that could bring about long-awaited updates to the 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge this week denied AstraZeneca’s request for a preliminary injunction against Mississippi’s contract pharmacy access law, marking the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal lawmakers late last week approved a pared-down, must-pass federal spending bill, which cut back on health center funding and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Senate Health, Education, Labor and Pensions (HELP) Committee—an influential panel with jurisdiction over the 340B program—will not only see [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Biogen will soon extend its contract pharmacy restrictions to non-hospital covered entities, while Novartis will require hospitals to submit claims [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Washington state could see greater cost reductions under a Medicaid fee-for-service pharmacy reimbursement model for 340B providers than through Medicaid [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Contract pharmacy restrictions—and legislation to override them—dominated 340B policy discussions in statehouses and courtrooms across the country this year, as [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
From drugmakers proposing new controversial 340B rebate models to federal lawmakers unveiling their first draft of a bipartisan-backed proposal to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
U.S. Rep. Earl “Buddy” Carter (R-Ga.), a pharmacist who has advocated for major changes to the 340B program which many [...] …